A Kerfati

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

A. Kadiri, A. Chraibi, F. Marouan, 1998, Diabetes research and clinical practice.